Literature DB >> 10993856

Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting.

T Levy1, G Fotopoulos, S Walker, S Rex, M Octave, V Paul, M Amrani.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common problem after CABG. Prevention with prophylactic drug therapy has had limited success, therefore alternative approaches are required. This study investigated the role of biatrial pacing compared with no pacing on AF incidence after isolated first-time CABG. METHODS AND
RESULTS: During surgery, temporary pacing leads were placed in the lateral wall of the right atrium and at the roof of the left atrium in Bachmann's bundle to allow bipolar pacing and sensing at each site. After surgery, all patients were connected to an external pacemaker (Chorum ELA) that also acted as a Holter monitor. Patients were consecutively randomized to either 4 days of biatrial pacing at a base rate of 80 bpm or to no pacing (control group, base rate 30 bpm). End points included an episode of AF lasting >1 hour on pacemaker Holter, clinically detected AF, intensive care unit (ICU) and hospital stay, and postoperative complications. One hundred thirty patients were randomized. Biatrial pacing significantly reduced both monitored (13.8% versus 38.5%, P:=0.001) and clinical (10.8% versus 33.8%, P:=0.002) episodes of AF. Median ICU (19 versus 24 hours, P:=NS) and mean hospital stay (7.7+/-6.9 versus 9.7+/-10, P:=NS) did not significantly change. The number of postoperative complications was lower in the biatrial group (13 versus 35, P:=0. 001).
CONCLUSIONS: Biatrial pacing after CABG significantly decreases the incidence of AF. This is associated with reduced postoperative complications and a trend toward reduced ICU and hospital stay.

Entities:  

Mesh:

Year:  2000        PMID: 10993856     DOI: 10.1161/01.cir.102.12.1382

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Permanent pacing: new indications.

Authors:  M R Gold
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Device-based therapies for atrial fibrillation.

Authors:  Gregory K Bruce; Paul A Friedman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

Review 3.  Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.

Authors:  E Bidar; S Bramer; B Maesen; J G Maessen; U Schotten
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 4.  Atrial Fibrillation in the Wolff-Parkinson-White Syndrome.

Authors:  Osmar Antonio Centurion
Journal:  J Atr Fibrillation       Date:  2011-05-04

Review 5.  Atrial Fibrillation: The New Epidemic of the Ageing World.

Authors:  Wilbert S Aronow; Maciej Banach
Journal:  J Atr Fibrillation       Date:  2009-04-01

6.  New insights into onset mechanisms of atrial fibrillation and flutter after coronary artery bypass graft surgery.

Authors:  A D Taylor; J G Groen; S L Thorn; C T Lewis; A J Marshall
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 7.  Amiodaron in atrial fibrillation: post coronary artery bypass graft.

Authors:  Paria Habibollahi; Shahrzad Hashemi Jam; Samad Shams Vahdati; Hamidreza Morteza Baghi; Hassan Amiri
Journal:  World J Emerg Med       Date:  2016

Review 8.  Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature.

Authors:  R A Archbold; R J Schilling
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 9.  Rate Control Strategy Elevated To Primary Treatment For Atrial Fibrillation: Has The Last Word Already Been Spoken?

Authors:  Osmar Antonio Centurión; Akihiko Shimizu
Journal:  J Atr Fibrillation       Date:  2014-12-31

Review 10.  Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.

Authors:  Yousef Rezaei; Mohammad Mehdi Peighambari; Shayan Naghshbandi; Niloufar Samiei; Alireza Alizadeh Ghavidel; Mohammad Reza Dehghani; Majid Haghjoo; Saeid Hosseini
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.